Why the Watchdog Won’t Bite: U.S. Food and Drug Administration Challenges
نویسنده
چکیده
Section Editor: Mark I. Langdorf, MD MHPE Submission history: Submitted September 20, 2016; Revision received ; Accepted Electronically published November 4, 2016 Full text available through open access at http://escholarship.org/uc/uciem_westjem DOI: 10.5811/westjem.2016.9.32492 [West J Emerg Med. 2016;17(6)747-8.] Lewis Katz School of Medicine at Temple University, Department of Clinical Emergency Medicine, Philadelphia, Pennsylvania
منابع مشابه
New Challenges for Biopharmaceutical Process Development.PDF
The U.S. Food and Drug Administration (FDA), through the Center for Biologics Evaluation and Research (CBER)/Center for Drug Evaluation and Research (CDER), has long identified that the development of biopharmaceutical products is becoming increasingly challenging, and is inefficient and costly. The agency has also commented that superior product-development sciences are needed to address the c...
متن کاملThe Conundrum of Online Prescription Drug Promotion; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
This commentary discusses pertinent issues from Hyosun Kim’s paper on online prescription drug promotion. The study is well-designed and the findings highlight some of the consequences of the Food and Drug Administration’s (FDA’s) decision to deregulate online advertising of prescription drugs. While Kim’s findings confirm some of the early concerns, they also provide a perspective of implement...
متن کاملReducing nicotine in cigarettes Challenges and opportunities
I n a July 28 announcement, Dr. Scott Gottlieb, recently appointed as the 23rd commissioner of the U.S. Food and Drug Administration (FDA), committed his agency to introduce a new guiding philosophy for the regulation of tobacco and nicotine. The associated news release set out the agency’s desire for a “new comprehensive plan for tobacco and nicotine regulation” and for an “approach [that] pla...
متن کاملDigital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”
The adoption and use of digital forms of direct-to-consumer advertising (also known as “eDTCA”) is on the rise. At the same time, the universe of eDTCA is expanding, as technology on Internet-based platforms continues to evolve, from static websites, to social media, and nearly ubiquitous use of mobile devices. However, little is known about how this unique form of pharmaceutical marketing impa...
متن کاملPharmacogenomics: why standard codeine doses can have serious toxicities or no therapeutic effect.
T hree children died in August 2012 after receiving usual doses of codeine for postoperative pain following a tonsillectomy and/or adenoidectomy (U.S. Food and Drug Administration [FDA], 2013a). Those incidents, combined with a case report of a breast-feeding infant who died in 2005 of an apparent overdose after the mother received a standard dose of codeine for episiotomy pain (Health Sciences...
متن کامل